Home | Search | Results place holder

Search Results



place holder place holder place holder place holder place holder place holder place holder place holder

Results for 'Metabolic Syndrome: Pipeline Analysis and U.S. Market Forecast'

Title Sort Publication Date Sort Price Sort Relevance Sort
place holder


Drug Treatments for Leading Endocrine and Metabolic Diseases

 February 2007 £3265 50 %
Stakeholder Insight: Metabolic Syndrome
Multiple definitions complicate treatment

 April 2006 £8690 35 %
Shionogi: Pipeline • Products • Performance • Potential

 March 2008 £595 26.95 %
Innovations in The Management of Diabetes
Next generation treatments and market dynamics

 June 2008 £1995 24 %
World Diabetes Market, The
2005-2011

 March 2006 £1499 21 %
Commercial Insight: Antidiabetics
Patent expiries and cost containment initiatives balanced by pipeline products

 August 2006 £8695 17.85 %
Commercial Insight: Antihypertensives
New challenges for a maturing market

 September 2006 £8000 17.5 %
Diabetes, Metabolic Syndrome and Cardiovascular Disease Markets
Reshaping Tomorrow's Diabetes Market

 October 2005 £1345 17.15 %
Obesity Drug Discoveries: what the future holds + Obesity Tracker

 August 2007 £995 16.1 %
Obesity Drug Discoveries: what the future holds

 August 2007 £1425 16.1 %
Commercial and Pipeline Perspectives: Obesity
Lack of Reimbursement Limits Market Potential

 December 2006 £6000 16.1 %
Pipeline/Commercial Insight: Antihypertensives New class opportunity offset by key patent expiries

 July 2007 £7600 15.05 %
Commercial Insight: Antidyslipidemics
Branded statins beware, generics are amongst you

 July 2006 £8440 14.35 %
Commercial Insight: Antidyslipidemics - The competitive cost-conscious antidyslipidemics market presents challenges

 July 2007 £7600 14.35 %
Commercial Insight: Cardiovascular market overview
Raft of patent expires threaten blockbusters

 October 2007 £7600 12.6 %
Anti-Obesity Treatments 2007-2012 - A blockbuster target market

 July 2007 £1799 11.2 %
place holder